Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

Overview of attention for article published in Respiratory Research, June 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet

policy: 1 policy source

Citations

dimensions_citation: 281 Dimensions

Readers on

mendeley: 164 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management : Full guideline

Cited by National Institute for Health and Care Excellence on 17 Jul 2019

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management: June 2010: full guideline

Cited by National Institute for Health and Care Excellence on 05 Dec 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management: Full guideline

Cited by National Institute for Health and Care Excellence on 22 Jun 2010

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.